Abstract | OBJECTIVE: To evaluate the relationship between high initial blood pressure and functional outcome in patients with acute stroke. DESIGN: An observational study based on the data from the Intravenous Nimodipine West European Stroke Trial (INWEST). INWEST was a placebo-controlled randomized study terminated prematurely; subsequent analysis found a correlation between diastolic BP (DBP) reduction caused by high-dose nimodipine and unfavourable outcome. Subjects. Of the 295 patients with acute ischaemic stroke (within 24 h) recruited in the INWEST, 265 were included in this analysis [n = 92 for placebo, n = 93 for low-dose nimodipine (1-mg h(-1)) and n=80 for high-dose nimodipine (2-mg h(-1))]. Definition. Initial BP was defined as BP at the time of randomization. Normal initial BP (NIBP)=systolic BP (SBP) 120-160 and DBP 60-90 mmHg (n=126). Four alternatives were defined as high initial BP (HIBP): (1) >160/90 (n=126), (2) >170/95 (n=106), (3) >180/100 (n=63), (4) >190/105 (n=45). Main outcome measures. Combined death or dependency (DD) (Barthel index < 60) at 21 days. RESULTS: In multiple logistic regression analyses, the odds ratio [OR] for DD at day 21 was significantly higher in patients with any definition of HIBP than with NIBP. For all patients, OR and 95% confidence intervals [CI] for 160/90 versus NIBP=3.1, 1.3-7.3, respectively; for 170/95=3.3, 1.4-8.1; for 180/100=7.0, 2.1-22.8; for 190/105=3.7, 1.1-12.4. For only placebo patients, OR and 95% CI for 160/90=4.8, 1.2-19.3; for 170/95=4.4, 1.1-17.8; for 180/100=12.7, 2.2-74.7; for 190/105=5.6, 1.1-30.0. The outcome was similar at 24 weeks but did not reach statistical significance for the placebo patients. CONCLUSION: Patients with HIBP had a poor functional outcome after acute stroke.
|
Authors | N Ahmed, G Wahlgren |
Journal | Journal of internal medicine
(J Intern Med)
Vol. 249
Issue 5
Pg. 467-73
(May 2001)
ISSN: 0954-6820 [Print] England |
PMID | 11350571
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Calcium Channel Blockers
- Nimodipine
|
Topics |
- Acute Disease
- Aged
- Antihypertensive Agents
(therapeutic use)
- Blood Pressure
- Calcium Channel Blockers
(therapeutic use)
- Clinical Trials as Topic
- Female
- Follow-Up Studies
- Humans
- Hypertension
(etiology, prevention & control)
- Logistic Models
- Male
- Nimodipine
(administration & dosage, therapeutic use)
- Prognosis
- Retrospective Studies
- Stroke
(complications, drug therapy, physiopathology)
- Survival Analysis
|